Suncoast Equity Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Suncoast Equity Management's LLY Position: Q2 2026 in Review
Suncoast Equity Management reduced its Eli Lilly (LLY) stake by 8.3% in Q2 2026, selling an estimated $3.29M and leaving 35,727 shares worth $42.9M. The position accounts for 5.37% of the portfolio, ranked #5.
Suncoast Equity Management first reported a position in LLY in Q2 2020 and has held it in 25 quarters since. The position peaked at $45.9M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Suncoast Equity Management held 35,727 shares of Eli Lilly worth $42.9M as of Q2 2026.
- Suncoast Equity Management sold 3,224 Eli Lilly shares in Q2 2026, an estimated $3.29M.
- Eli Lilly made up 5.37% of Suncoast Equity Management's portfolio in Q2 2026, its #5 holding.
- Suncoast Equity Management first reported a position in Eli Lilly in Q2 2020 and has held it in 25 quarters since.
- Suncoast Equity Management's Eli Lilly position peaked at $45.9M in Q4 2025.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Suncoast Equity Management's 13F filing for Q2 2026, filed 4 Aug 2026.